Recent years have seen a dramatic rise in the number of cases of tuberculosis worldwide, and as a result, there has been an upsurge in the demand for the isolation and characterization of Mycobacterium tuberculosis isolates. In their recent articles, Ruddy et al. (4) and de Boer et al. (2) described the incidence of false-positive cultures of M. tuberculosis in routine microbiology laboratories in London and The Netherlands, respectively. While we agree with their findings in principle, we feel that their experience does not translate well to the situation that prevails in laboratories serving areas with a high incidence of tuberculosis. While their rates of cross-contamination were low (0.54 and 2.4%), so was the average number of positive isolates handled by each laboratory per week, which in itself limits the potential for cross-contamination. We particularly feel that one of their criteria for the definition of a crosscontamination event, i.e., an isolate with a fingerprint that is identical to that of another isolate processed within 7 days, is unrealistic. In a recent paper (1), we reported on the implementation of a set of measures that resulted in the reduction of the cross-contamination rate for the processing of sputum for the culture of M. tuberculosis from 7.3 to 2.1%. In contrast to the situation in London and The Netherlands, our laboratory has a culture positivity rate of 55%, which translates into approximately 24 positive cultures per week. In addition, the incidence of tuberculosis in the area is very high (3), with a high degree of molecular clustering. In such a scenario, the exclusion, as a cross-contamination event, of isolates with identical DNA fingerprints that were cultured within 7 days of each other cannot always be correct. We found that the majority of cross-contamination events were associated with processing of culture-negative specimens in the same batch as smear-positive samples obtained within the first 3 days of treatment. The modifications we made to laboratory procedures were designed to limit the opportunity for the transfer of bacilli from positive to negative samples without increasing the workload. As we could not limit the number of smear-positive samples processed per day, we ensured that the order of sputum processing went from negative to positive specimens. We also designated a specific safety cabinet for dealing exclusively with sputum samples, and all positive cultures, whether in liquid or on solid media, were dealt with in another cabinet.
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It is necessary to point out that these options are accessible to all laboratories, regardless of their level of expertise and financial support. The procedural modifications we implemented were effective at reducing the rate of cross-contamination but did not have an impact on our output, and they can be effectively applied by any laboratory, whether in a routine or clinical-trial situation, without extensive economic outlay. 
Authors' Reply (reference 4)
Carroll et al. correctly point out an important point about our study of cross-contamination in London microbiology laboratories (1), i.e., that its conclusions are only relevant to laboratories with similar resources and practices. Although the number of new cases in a busy London laboratory is lower than that in South Africa, it is more usual for multiple specimens to be sent and processed, with the result that the laboratory has many times the number of isolates than positive patients. In many countries in sub-Saharan Africa, financial constraints mean that only a proportion of samples are cultured.
The higher degree of molecular clustering that van Helden's group has described (2) may indeed be a reason why two isolates may have the same IS6110 pattern without being caused by laboratory cross-contamination. It is prudent to separate work with specimens from work with cultures, although few African laboratories have the luxury of two exhaust-protective cabinets. The idea that cross-contamination may be limited by separating smear-positive and smear-negative specimens is superficially attractive but may not be effective. An important lesson of our paper was that some of our patients had presumed cross-contamination although they did have tuberculosis. In other words, the isolate that the laboratory reported on was not the one that was responsible for the infection in that patient, a finding that would be important in areas where resistance is common. We believe that in a laboratory that processes specimens with a high culture positivity rate, this series of events may occur often and would not be prevented by separating smear-positive and smear-negative specimens. Ultimately, it is only by rigorous laboratory procedures to limit aerosol production and splashing when processing specimens that cross-contamination can be kept to a minimum (1). 
